TMEM16A (ANO1) as a therapeutic target in cystic fibrosis

LJV Galietta - Current opinion in pharmacology, 2022 - Elsevier
Cystic fibrosis (CF) is a multi-organ genetic disease caused by loss of function of CFTR, a
cAMP-regulated chloride channel expressed in epithelial cells. In airway epithelia, CFTR …

The pharmacology of the TMEM16A channel: therapeutic opportunities

R Al-Hosni, Z Ilkan, E Agostinelli, P Tammaro - Trends in Pharmacological …, 2022 - cell.com
The TMEM16A Ca 2+-gated Cl− channel is involved in a variety of vital physiological
functions and may be targeted pharmacologically for therapeutic benefit in diseases such as …

Analysis of inhibitors of the anoctamin‐1 chloride channel (transmembrane member 16A, TMEM16A) reveals indirect mechanisms involving alterations in calcium …

M Genovese, M Buccirossi, D Guidone… - British journal of …, 2023 - Wiley Online Library
Background and Purpose Pharmacological inhibitors of TMEM16A (ANO1), a Ca2+‐
activated Cl− channel, are important tools of research and possible therapeutic agents …

[PDF][PDF] Genome‐wide analysis identifies gallstone‐susceptibility loci including genes regulating gastrointestinal motility

CJ Fairfield, TM Drake, R Pius, AD Bretherick… - …, 2022 - Wiley Online Library
Abstract Background and Aims Genome‐wide association studies (GWAS) have identified
several risk loci for gallstone disease. As with most polygenic traits, it is likely that many …

Arctigenin, a novel TMEM16A inhibitor for lung adenocarcinoma therapy

S Guo, Y Chen, S Shi, X Wang, H Zhang, Y Zhan… - Pharmacological …, 2020 - Elsevier
TMEM16A plays critical roles in physiological process and may serve as drug targets for
diverse diseases. Recently, TMEM16A has started to be regarded as potential primary lung …

Calcium-sensing receptor activator cinacalcet for treatment of cyclic nucleotide-mediated secretory diarrheas

T Chu, P Yottasan, L de Souza Goncalves, AA Oak… - Translational …, 2024 - Elsevier
Cyclic nucleotide elevation in intestinal epithelial cells is the key pathology causing
intestinal fluid loss in secretory diarrheas such as cholera. Current secretory diarrhea …

Chloride transport modulators as drug candidates

AS Verkman, LJV Galietta - American Journal of Physiology …, 2021 - journals.physiology.org
Chloride transport across cell membranes is broadly involved in epithelial fluid transport, cell
volume and pH regulation, muscle contraction, membrane excitability, and organellar …

[HTML][HTML] Small-molecule inhibitor of intestinal anion exchanger SLC26A3 for treatment of hyperoxaluria and nephrolithiasis

O Cil, T Chu, S Lee, PM Haggie, AS Verkman - JCI insight, 2022 - ncbi.nlm.nih.gov
Nephrolithiasis is a common and recurrent disease affecting 9% of the US population.
Hyperoxaluria is major risk factor for calcium oxalate kidney stones, which constitute two …

TMEM16A: An alternative approach to restoring airway anion secretion in cystic fibrosis?

H Danahay, M Gosling - International Journal of Molecular Sciences, 2020 - mdpi.com
The concept that increasing airway hydration leads to improvements in mucus clearance
and lung function in cystic fibrosis has been clinically validated with osmotic agents such as …

[HTML][HTML] SLC26A6-selective inhibitor identified in a small-molecule screen blocks fluid absorption in small intestine

O Cil, PM Haggie, JAT Tan, AA Rivera, AS Verkman - JCI insight, 2021 - ncbi.nlm.nih.gov
SLC26A6 (also known as putative anion transporter 1 [PAT1]) is a Cl–/HCO 3–exchanger
expressed at the luminal membrane of enterocytes where it facilitates intestinal Cl–and fluid …